Protective Effect of Theaflavin-3-digallate on Lipopolysaccharide-induced Inflammation Injury in Macrophage Cells

Yanting Wu,Fujun Jin,Junwei Liu,Danlin Zheng,Yiliang Wang,Feiyan Wu,Yexuan Zhu,Yifei Wang
DOI: https://doi.org/10.3923/ijp.2017.980.989
2017-01-01
International Journal of Pharmacology
Abstract:Background and Objective: Inflammation is a defensive response against a multitude of harmful stimuli and stress conditions such as tissue injury and is one of the most common pathological processes of human diseases. Tumor Necrosis Factor-alpha (TNF-alpha), interleukin-1 beta (IL-1 beta) and interleukin-6 (IL-6) play important roles during the inflammatory state. The aim of this study was to investigate the suppressive effects of theaflavin-3-digallate on lipopolysaccharide (LPS)-induced inflammation in U937 and RAW 264.7 cells. Materials and Methods: The U937 and RAW 264.7 cells were treated with 100 ng mL(-1) LPS in the presence of theaflavin-3-digallate (6.25-50 mu M). The qRT-PCR assay was used to test the levels of TNF-alpha, IL-1 beta and IL-6 in LPS-treated Phorbol Myristate Acetate (PMA)-primed U937 and murine RAW 264.7 cells and Western blot assays were used to identify potential mechanism of anti-inflammatory potential of the theaflavin-3-digallate. Significance between groups data were analyzed by Graph Pad Prism 5.0, using Student's t-test, One-way ANOVA. Results: The present study has clearly shown that theaflavin-3-digallate markedly decreased the mRNA expression of TNF-alpha, IL-1 beta and IL-6 in a dose-dependent manner. Moreover, western blot analyses demonstrated that theaflavin-3-digallate also blocked phosphorylation of I kappa B from cytosolic fraction and reduced LPS-induced nuclear accumulation of transcription factor nuclear factor-kappa B (NF-kappa B) p65. Conclusion: These results demonstrated that theaflavin-3-digallate might abolish inflammation in RAW 264.7 macrophages and PMA-primed U937 cells via NF-kappa B pathway.
What problem does this paper attempt to address?